Skip to main content

Tilray Inc. Corrects Despite Much Improved Q4 Financial Results

Tilray's revenue beat analysts' expectations, increasing by 10%, with cannabis revenue up 31% and hemp revenue down 23%.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.